RE: This Weeks RNS10 Apr 2022 13:28
Captain- RNS dated Mar7th "the transitional services agreement addresses the ongoing requirements for the site to continue to produce Lateral Flow Tests for Omega,particularly the Visitect CD4 advanced disease test.These arrangements cover the period to December 2022" So for the next 8 months tests will be produced at Alva for Omega . So no production costs for these tests .
RNS dated April 7th " order intake is running well ahead of available production and the long term prospects remain undeminished for the rollout of Visitect CD4 advanced disease test"
so at the moment we cannot make enough tests even if as you and other posters on here keep on saying something happens to that test the other tests will use the capacity up and these tests retail for more so does that not mean more profit .